Benoit Leclerc Email & Phone Number

Ottawa, Canada Area

• Since therapeutic compounds are on the way to treat Alzheimer’s disease, there is an increasing unmet biomedical research for developing new molecular agents to detect the early stages of Alzheimer’s disease using.
• Examined in vitro binding properties of conjugated nanobodies prior to IV injection and deployed MX2 systems coupled with pharmacokinetics assays to identify drug ADME upon mice anesthetic inhalation.
• Identified the presence of peptides in the brain’s blood path at severely low retention rates, resulting in a lack of molecules crossing the blood brain barrier.
• Reviewed and lent industry expertise towards a $240K grant application from the Alzheimer’s Association and contributed to the analysis and evaluation of fellowship applications and project amendments.

Saint Paul, Minnesota

• Improving animal production via practices and knowledge add value to agricultural economy. To fulfill this mission I investigated the photoperiodic modulation of the clocks, monoamines and photoreceptors in.
• Assessed clock gene expression in phenotypic neurons following circadian rhythm and night interruption studies to understand gene expression patterns in the brain.
• Modulated ovarian follicles sizes across the reproductive cycle by changing various photoperiodic treatments.
• Identified the presence of desensitization in multiple neurons through the study of melanopsin and dopamine expression within the PMM neurons to track down the mechanisms of hormones expression in the pituitary gland.

Doctor Of Philosophy, Molecular Biology

Master Of Science, Veterinary Bacteriology And Pathology

Bachelor Of Science, Molecular Biology